Loading insider details...
Beta
Latest Form 4 (Sep 23, 2026): Purchase of 5,000 INBX shares, $500.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 5,000 | $500.0K |
| Sep 17, 2026 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 5,000 | $500.0K |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 5,000 | $567.6K |
| Jun 4, 2026 | Inhibrx Biosciences, Inc. (INBX) | Grant/Award | 15,000 | n/a |
| Jan 6, 2026 | BIODESIX INC (BDSX) | Grant/Award | 5,443 | n/a |
| May 29, 2025 | Inhibrx Biosciences, Inc. (INBX) | Grant/Award | 15,000 | n/a |
| May 22, 2025 | BIODESIX INC (BDSX) | Grant/Award | 68,621 | n/a |
| Mar 28, 2025 | Inhibrx Biosciences, Inc. (INBX) | Gift | 90,000 | n/a |
| Dec 17, 2024 | Inhibrx Biosciences, Inc. (INBX) | Gift | 500,000 | n/a |
| Dec 6, 2024 | Inhibrx Biosciences, Inc. (INBX) | Gift | 52,000 | n/a |